CB

Caelum Biotech

High
Life Sciences · Life Sciences · Boston, US · Broker Lockton · UW R. Tanaka
GWP
$2.10M
Renewal in
47d
Loss ratio
41%
YoY
+28%+28%
Open claims
1
Cross-sell
$1.40M
Loss ratio
41%
Within target
Combined ratio
76%
Profitable
Claims YTD
3
1 open
Growth YoY
+28%
Coverage spend
$2.10M
Frequency · YTD
Claims by product
What this meansHighest frequency in Product Liability — investigate root-cause and consider deductible reset.
24-month trend
Loss ratio (%)
What this meansCurrent LR 41% vs 24-mo avg 39%.
Wallet allocation
Coverage line by spend
Clinical Trials$620K
Product Liability$880K
Property$410K
Cyber$190K
Claims severity
Severity index by product
What this meansSeverity scale 0–10. Focus mitigation on lines scoring >5.
AI portfolio analysis
Synthesising portfolio view…
AI